Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/35586
Title: Chronopharmacokinetics of Mycophenolic Acid and Its Glucuronide and Acyl Glucuronide Metabolites in Kidney Transplant Recipients Converted From Cyclosporine to Everolimus
Authors: Tedesco-Silva, Helio [UNIFESP]
Felipe, Claudia Rosso [UNIFESP]
Slade, Alan
Schmouder, Robert L.
Medina Pestana, Jose Osmar [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Novartis Inst Biomed Res
Novartis Pharmaceut
Keywords: mycophenolic acid
cyclosporine
everolimus
pharmacokinetics
circadian variation
Issue Date: 1-Dec-2012
Publisher: Lippincott Williams & Wilkins
Citation: Therapeutic Drug Monitoring. Philadelphia: Lippincott Williams & Wilkins, v. 34, n. 6, p. 652-659, 2012.
Abstract: Background: the influence of the conversion from cyclosporine (CsA) to everolimus (EVR) on the chronopharmacokinetics of mycophenolic acid (MPA) and its glucuronide (MPAG) and acyl glucuronide (acyl-MPAG) metabolites in patients receiving enteric-coated mycophenolate sodium (EC-MPS) has not been studied.Methods: We evaluated daytime and nighttime steady-state MPA, MPAG, and acyl-MPAG pharmacokinetics in 24 stable kidney transplant recipients while receiving cyclosporine and 28 days after conversion from CsA to EVR. the effect of concomitant treatment and the circadian difference on AUC(t,ss) and C-max,C-ss were assessed using a linear mixed model.Results: After conversion from CsA to EVR, MPA AUC(t,ss) was 43% higher (29% daytime and 58% during nighttime), whereas MPAG AUC(t,ss) was 33% lower (35% daytime and 30% during nighttime) and acyl-MPAG AUC(t,ss) was 31% lower (36% during daytime and 26% nighttime). Compared with daytime, MPA AUC(t,ss) was 25% lower (32% with CsA and 17% with EVR), MPAG AUC(t,ss) was 24% lower (26% with CsA and 21% with EVR), and acyl-MPAG AUCt, ss was 26% lower (32% with CsA and 21% with EVR) during nighttime. After conversion from CsA to EVR, MPAG: MPA and acyl-MPAG: MPA AUC(t,ss) ratios were 50% lower but were not different during daytime compared with nighttime EC-MPS administration. There was no correlation between CsA or EVR concentrations with MPA, MPAG, and acyl-MPAG exposures during daytime and nighttime. At least 1 adverse event was reported in 70.8% of patients receiving EC-MPS and CsA and in 91.7% receiving EC-MPS and EVR.Conclusion: in stable kidney transplant recipients receiving EC-MPS and steroids, exposures to MPA, MPAG, and acyl-MPAG were lower during nighttime compared with daytime, both with CsA or EVR. This circadian effect on MPA exposure did not correlate with CsA or EVR concentrations or with altered MPAG and acyl-MPAG formation.
URI: http://repositorio.unifesp.br/handle/11600/35586
ISSN: 0163-4356
Other Identifiers: http://dx.doi.org/10.1097/FTD.0b013e3182706ef1
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.